In a tactical initiative to improve drug safety oversight, Tech Mahindra, a worldwide frontrunner in technology consulting and digital services, has revealed an AI-based pharmacovigilance (PV) solution utilizing NVIDIA AI software. The solution seeks
Zydus Lifesciences Limited has established itself as a strong player in the world oncology market with its recent FDA approval to manufacture and sell a generic version of Apalutamide 60 mg tablets for the treatment of prostate cancer. The drug will
A major achievement for India's biotech industry and cancer treatment has occurred as the Delhi-based startup Cellogen Therapeutics has received...
The main SGLT2 inhibitor Xenia (empagliflozin and its combos) was introduced by USV, an Indian global healthcare business, to treat type 2 diabetes patients' heart failure, chronic renal disease, and glycaemic management.
LONDON, UK - March 19: The much-anticipated second annual edition of the Biotechnology Show continues to attract industry giants, creating a powerful platform for innovation, collaboration, and deal-making.
HaystackAnalytics has launched 'TB One,' a Make-in-India solution aimed at improving TB diagnosis through next-generation sequencing (NGS) in any diagnostic laboratory or hospital.
According to clinical trial results published in The Lancet Haematology, a locally created CAR T-cell immunotherapy has demonstrated a 73% response rate in patients with leukemia and lymphoma, marking a significant achievement for cancer therapy in I
The application of AI in medicine for early diagnoses, and especially cancer prediction, has been acknowledged to be a significant scientific achievement. In India...
Sun Pharmaceutical Industries subsidiary TARO Pharmaceuticals Inc. has completed the 100% acquisition of Antibe Therapeutics Inc., a...
AstraZeneca announced that it has made a deal to take over EsoBiotec, a biotechnology company focused on in vivo cell therapies. EsoBiotec has come up with a new way of using engineered...
, CDSCO.jpg)
